Form 4: Dynavax Technologies Corp: SVP and CMO Robert Janssen Reports Stock Transactions

Robert Janssen, SVP and CMO of Dynavax Technologies, reports the vesting of restricted stock units and subsequent tax withholding.

Summary

• On February 18, 2025, Robert Janssen, SVP and CMO of Dynavax Technologies Corp, reported transactions involving Dynavax common stock.
• Janssen vested 11,904 Restricted Stock Units (RSUs), each representing a contingent right to receive one share of common stock.
• The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 15, 2024.
• Dynavax withheld 4,041 shares at a price of $12.93 to satisfy tax withholding requirements on the vesting of these RSUs.
• Following these transactions, Janssen directly owns 77,485 shares of Dynavax common stock and 23,806 Restricted Stock Units.

Sentiment

Score: 5

Explanation: This is a routine filing related to executive compensation. It doesn't inherently indicate positive or negative sentiment.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track management's holdings and potential alignment with shareholder interests.

Stakeholder Impact

• The transaction provides transparency to shareholders regarding executive compensation and stock ownership.

Key Dates

Keywords

Dynavax Technologies, Robert Janssen, Form 4, Stock Transaction, RSU, Tax Withholding, Beneficial Ownership, DVAX